2016 Global Nucleic Acid Testing/NAT Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities–Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing

1398 pages report Published in
Diagnostics
Publisher: Venture Planning Group

arrowFor This Report

“This new seven-country study from VPGMarketResearch.com contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years.

Highlights

– Business and technological trends in seven major markets: France, Germany, Italy, Japan, Spain,
UK, and US
– Five-year test volume and sales forecasts
– Market shares of leading competitors
– Feature comparison of major analyzers
– Profiles of market players and start-up firms developing innovative technologies
and products
– Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Geographic Coverage

– France
– Germany
– Italy
– Japan
– Spain
– UK
– USA

Worldwide Market Overview

– Laboratories performing DNA sequencing and molecular diagnostic testing by country and market
segment.

– Five-year test volume and sales projections by country.

Market Segmentation Analysis

– Sales and market shares of major suppliers of molecular diagnostic reagent kits and components.

– Five-year test volume and sales forecasts for major applications, including:

– Infectious Diseases – Forensic Testing
– Cancer – Paternity Testing/HLA Typing
– Genetic Diseases – Others

– Five-year test volume and sales projections for over 30 NAT assays.

– A comprehensive analysis of the sequencing market, by country and laboratory segment,
including:

– Industrial – Academic
– Government – Commercial

– Detailed market segmentation analysis, including review of the market dynamics, trends,
structure, size, growth and major suppliers, by country.

Product/Technology Review

– Comparison of leading molecular diagnostic analyzers from Abbott, Beckman Coulter, BD,
Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

– Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over 30 target/signal amplification methods, including:

– PCR – bDNA
– SDA – NASBA
– TMA – SSSR, and others
– LCR

– Worldwide listings of companies, universities and research centers developing new molecular-
diagnostic technologies and products.

Competitive Assessments

– Extensive strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements and
new technologies/products in R&D.

– Comprehensive listings of companies developing and marketing molecular diagnostics products,
by test and application.

Opportunities and Strategic Recommendations

– Specific new product development opportunities with potentially significant market appeal
during the next five years.

– Design criteria for new products.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch.com proprietary data base was conducted.

Table of Contents

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies For Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge And Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Review
A. DNA Sequencing
1. Introduction
2. Sequencing Methods
3. Autoradiography
4. The Human Genome Project
5. Sequencing Automation
6. Image Scanners
7. Fluorescent Detection
8. Gene Profiling
9. Gene Expression
10. Polymorphism Screening
11. Protein Interaction Networks
B. DNA and RNA Probe Technologies
1. Basic Principles
2. Probe Preparation
3. The DNA Probe Test
4. Test Formats
5. Labeling Techniques
6. Amplification Methods
C. Detection Technologies
1. Radioactive Methods
a. Overview
b. Major Isotopes
- P-32
- S-35
- H-3
- I-125
2. Non-Isotopic Methods
a. Enzymatic Labels
b. Chemical Labeling
- Indirect Chemical Labeling
- Direct Chemical Labeling
c. Fluorescence
d. Chemiluminescence
e. Electrical Conductivity
D. Molecular Diagnostic Instrumentation Review
1. Abbott LCx
2. Beckman Coulter/Biomek FK
3. BD Viper System with XTR Technology
4. BD Innova
5. Becton Dickinson SDA
6. bioMerieux NucliSENS easyMAG
7. bioMerieux NucliSENS easyQ and MiniMAG
8. Bio-Rad GeneScope
9. Cepheid GeneXpert
10. Curetis Unyvero
11. GenMark Dx eSensor XT-8
12. Hologic/Gen-Probe Panther
13. Hologic/Gen-Probe Tigris/DTS
14. HTG Molecular Edge
15. Life Technologies QuantStudio Dx
16. Qiagen QIAsymphony RGQ
17. Roche Cobas Amplicor
18. Roche Cobas TaqMan 48
19. Roche Cobas TaqMan
20. Roche Cobas TaqMan AmpliPrep
21. Roche LighCycler 480
22. Roche Cobas 4800
23. Roche Cobas s 201
24. Siemens Versant
25. Tecan LS Series
E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
F. Pharmacogenomics
G. Major Applications
1. Microbiology/Infectious Diseases
a. Overview
b. Major Infectious Diseases
* AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
* Adenovirus
* Aeromonas
* Anthrax/Bacillus Anthracis
* Arboviruses
* Babesiosis
* Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
* Blastocystis Hominis
* Brucella
* Campylobacter
* Candida
* Chagas Disease
* Chancroid
* Chlamydia
* Clostridium Difficile
* Coronaviruses
* Coxsackieviruses
* Creutzfeldt-Jakob's Disease
* Cryptosporidium Parvum
* Cyclospora Cayetanensis
* Cytomegalovirus
* Ebola Virus
* E. Coli
* EchoVirus
* Encephalitis
* Enteroviruses
* Epstein-Barr Virus
* Giardia Lamblia
* Gonorrhea
* Granuloma Inguinale
* Hantavirus
* Helicobacter Pylori
* Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
* Herpes Simplex Virus
* Human Herpes Virus-6 (HHV-6)
* Influenza Viruses
* Legionella
* Lyme Disease
* Lymphogranuloma Venereum (LGV)
* Malaria
* Measles (Rubeola)
* Meningitis
* Microsporidium
* Mononucleosis
* Mumps
* Mycoplasma
* Papillomaviruses
* Parvovirus B19
* Pneumonia
* Polyomaviruses
* Pseudomonas Aeruginosa
* Rabies
* Respiratory Syncytial Virus (RSV)
* Rhinoviruses
* Rotavirus
* Rubella
* Salmonellosis
* Septicemia
* Shigellosis
* Staphylococcus Aureus
* Streptococci
* Syphilis
* Toxoplasmosis
* Trichomonas Vaginalis
* Tuberculosis
* Vibrio
* West Nile Virus
* Yersina
2. Cancer Testing
a. Overview
b. Major Cancer Types
* Prostate
* Lung
* Colon and Rectum
* Breast
* Skin
* Uterine
* Leukemia
* Oral
c. Oncogenes
- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
* Achondroplasia
* Autosomal Dominant Polycystic Kidney Disease
* Cancer
* Cosmetogenomics
* Cystic Fibrosis
* Down's Syndrome
* Duchenne and Becker Muscular Dystrophy
* Factor V (Leiden)
* Factor IX Deficiency
* Fragile X Syndrome
* Heart Disease
* Hemochomatosis
* Hemophilia
* Huntington's Disease
* Maternal-Fetal Incompatibility
* Multiple Endocrine Neoplasia
* Phenylketonuria (PKU)
* Polycystic Kidney Disease (PKD)
* Prenatal Screening
* Retinitis Pigmentosa
* Retinoblastoma
* Sickle Cell Anemia
* Spinal Muscular Atrophy
* Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes
* Multilocus Probes
* Single Locus Probes
* PCR and RFLP
c. The FBI
d. DNA Profile Data Banks
* U.S.A.
* U.K.
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe Market Expansion
* Technology Availability
* Use of Hair as Evidence
h. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
VII. Worldwide Market Overview
1. Business Environment
2. Market Structure
3. Market Size and Growth
VIII. France Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
IX. Germany Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
X. Italy Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XI. Japan Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XII. Spain Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XIII. U.K. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XIV. U.S.A. Molecular Diagnostics Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Test Volume and Sales Forecasts, Major Supplier Sales and Market Shares
XV. Competitive Assessments
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forensics/LabCorp
- Decode Genetics
- Diadexus
- Eiken
- Elitech Group
- Enzo
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- Kreatech/Leica
- Li-Cor Biosciences
- Monogram Biosciences/LabCorp
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
XVI. Appendix: Major Universities and Research Centers Developing Molecular Diagnostic Technologies

List of Tables

Major Companies Developing or Marketing AIDS Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic and Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic and Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases
Worldwide, Laboratories Performing DNA Sequencing by Country
Worldwide, Molecular Diagnostics Market Potential Laboratory Universe by Country
Worldwide, Molecular Diagnostic Test Volume Forecast by Country
Worldwide, Molecular Diagnostics Market Forecast by Country
France Molecular Diagnostics Test Volume And Sales by Major Application
France Laboratories Performing DNA Sequencing by Market Segment
France Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
France Molecular Diagnostics Test Volume by Major Application
France Major Infectious Disease Test Volume by Assay
France Major Infectious Disease Test Volume by Method
France Molecular Diagnostics Market by Major Application
France Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
France Major Infectious Disease Diagnostics Market by Assay
France AIDS Testing Market Estimated Sales by Major Supplier
France Adenovirus Testing Market Estimated Sales by Major Supplier
France Chlamydia Testing Market Estimated Sales by Major Supplier
France CMV Testing Market Estimated Sales by Major Supplier
France Gonorrhea Testing Market Estimated Sales by Major Supplier
France Hepatitis Testing Market Estimated Sales by Major Supplier
France Hepatitis C Testing Market Estimated Sales by Major Supplier
France HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
France Herpes Testing Market Estimated Sales by Major Supplier
France Influenza Testing Market Estimated Sales by Major Supplier
France Meningitis Testing Market Estimated Sales by Major Supplier
France Mycoplasma Testing Market Estimated Sales by Major Supplier
France RSV Testing Market Estimated Sales by Major Supplier
France Shigella Testing Market Estimated Sales by Major Supplier
Germany Molecular Diagnostics Test Volume And Sales by Major Application
Germany Laboratories Performing DNA Sequencing by Market Segment
Germany Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Germany Molecular Diagnostics Test Volume by Major Application
Germany Major Infectious Disease Test Volume by Assay
Germany Major Infectious Disease Test Volume by Method
Germany Molecular Diagnostics Market by Major Application
Germany Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Germany Major Infectious Disease Diagnostics Market by Assay
Germany AIDS Testing Market Estimated Sales by Major Supplier
Germany CMV Testing Market Estimated Sales by Major Supplier
Germany EBV Testing Market Estimated Sales by Major Supplier
Germany Gonorrhea Testing Market Estimated Sales by Major Supplier
Germany Hepatitis Testing Market Estimated Sales by Major Supplier
Germany Hepatitis C Testing Market Estimated Sales by Major Supplier
Germany HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Germany Herpes Testing Market Estimated Sales by Major Supplier
Germany Influenza Testing Market Estimated Sales by Major Supplier
Germany Meningitis Testing Market Estimated Sales by Major Supplier
Germany Mycoplasma Testing Market Estimated Sales by Major Supplier
Germany Pneumonia Testing Market Estimated Sales by Major Supplier
Germany RSV Testing Market Estimated Sales by Major Supplier
Germany Rotavirus Testing Market Estimated Sales by Major Supplier
Italy Molecular Diagnostics Test Volume And Sales by Major Application
Italy Laboratories Performing DNA Sequencing by Market Segment
Italy Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Italy Molecular Diagnostics Test Volume by Major Application
Italy Major Infectious Disease Test Volume by Assay
Italy Major Infectious Disease Test Volume by Method
Italy Molecular Diagnostics Market by Major Application
Italy Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Italy Major Infectious Disease Diagnostics Market by Assay
Italy AIDS Testing Market Estimated Sales by Major Supplier
Italy CMV Testing Market Estimated Sales by Major Supplier
Italy Gonorrhea Testing Market Estimated Sales by Major Supplier
Italy Hepatitis Testing Market Estimated Sales by Major Supplier
Italy Hepatitis C Testing Market Estimated Sales by Major Supplier
Italy HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Italy Herpes Testing Market Estimated Sales by Major Supplier
Italy Influenza Testing Market Estimated Sales by Major Supplier
Italy Meningitis Testing Market Estimated Sales by Major Supplier
Italy Mycoplasma Testing Market Estimated Sales by Major Supplier
Italy RSV Testing Market Estimated Sales by Major Supplier
Japan Molecular Diagnostics Test Volume And Sales by Major Application
Japan Laboratories Performing DNA Sequencing by Market Segment
Japan Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Japan Molecular Diagnostics Test Volume by Major Application
Japan Major Infectious Disease Test Volume by Assay
Japan Major Infectious Disease Test Volume by Method
Japan Molecular Diagnostics Market by Major Application
Japan Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Japan Major Infectious Disease Diagnostics Market by Assay
Japan AIDS Testing Market Estimated Sales by Major Supplier
Japan Chlamydia Testing Market Estimated Sales by Major Supplier
Japan CMV Testing Market Estimated Sales by Major Supplier
Japan Gonorrhea Testing Market Estimated Sales by Major Supplier
Japan Hepatitis Testing Market Estimated Sales by Major Supplier
Japan Hepatitis C Testing Market Estimated Sales by Major Supplier
Japan Herpes Testing Market Estimated Sales by Major Supplier
Japan Meningitis Testing Market Estimated Sales by Major Supplier
Japan Mycoplasma Testing Market Estimated Sales by Major Supplier
Japan Pneumonia Testing Market Estimated Sales by Major Supplier
Japan Shigella Testing Market Estimated Sales by Major Supplier
Spain Molecular Diagnostics Test Volume And Sales by Major Application
Spain Laboratories Performing DNA Sequencing by Market Segment
Spain Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
Spain Molecular Diagnostics Test Volume by Major Application
Spain Major Infectious Disease Test Volume by Assay
Spain Major Infectious Disease Test Volume by Method
Spain Molecular Diagnostics Market by Major Application
Spain Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
Spain Major Infectious Disease Diagnostics Market by Assay
Spain AIDS Testing Market Estimated Sales by Major Supplier
Spain Chlamydia Testing Market Estimated Sales by Major Supplier
Spain CMV Testing Market Estimated Sales by Major Supplier
Spain Gonorrhea Testing Market Estimated Sales by Major Supplier
Spain Hepatitis Testing Market Estimated Sales by Major Supplier
Spain Hepatitis C Testing Market Estimated Sales by Major Supplier
Spain HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
Spain Herpes Testing Market Estimated Sales by Major Supplier
Spain Influenza Testing Market Estimated Sales by Major Supplier
Spain Meningitis Testing Market Estimated Sales by Major Supplier
Spain Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Molecular Diagnostics Test Volume And Sales by Major Application
U.K. Laboratories Performing DNA Sequencing by Market Segment
U.K. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.K. Molecular Diagnostics Test Volume by Major Application
U.K. Major Infectious Disease Test Volume by Assay
U.K. Major Infectious Disease Test Volume by Method
U.K. Molecular Diagnostics Market by Major Application
U.K. Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
U.K. Major Infectious Disease Diagnostics Market by Assay
U.K. AIDS Testing Market Estimated Sales by Major Supplier
U.K. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis Testing Market Estimated Sales by Major Supplier
U.K. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.K. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.K. Influenza Testing Market Estimated Sales by Major Supplier
U.K. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.K. Pneumonia Testing Market Estimated Sales by Major Supplier
U.K. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. Molecular Diagnostics Test Volume And Sales by Major Application
U.S.A. Laboratories Performing DNA Sequencing by Market Segment
U.S.A. Molecular Diagnostics Market Potential Laboratory Universe by Market Segment
U.S.A. Molecular Diagnostics Test Volume by Major Application
U.S.A. Major Infectious Disease Test Volume by Assay
U.S.A. Major Infectious Disease Test Volume by Method
U.S.A. Molecular Diagnostics Market by Major Application
U.S.A. Molecular Diagnostics Market Estimated Sales and Market Shares of Major Suppliers
U.S.A. Major Infectious Disease Diagnostics Market by Assay
U.S.A. AIDS Testing Market Estimated Sales by Major Supplier
U.S.A. Adenovirus Testing Market Estimated Sales by Major Supplier
U.S.A. Chlamydia Testing Market Estimated Sales by Major Supplier
U.S.A. CMV Testing Market Estimated Sales by Major Supplier
U.S.A. Echovirus Testing Market Estimated Sales by Major Supplier
U.S.A. Enterovirus Testing Market Estimated Sales by Major Supplier
U.S.A. EBV Testing Market Estimated Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis Testing Market Estimated Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Estimated Sales by Major Supplier
U.S.A. HIV/Hepatitis Blood Screening NAT Market Reagent Sales by Major Supplier
U.S.A. Herpes Testing Market Estimated Sales by Major Supplier
U.S.A. Influenza Testing Market Estimated Sales by Major Supplier
U.S.A. Meningitis Testing Market Estimated Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Estimated Sales by Major Supplier
U.S.A. Pneumonia Testing Market Estimated Sales by Major Supplier
U.S.A. Rabies Testing Market Estimated Sales by Major Supplier
U.S.A. RSV Testing Market Estimated Sales by Major Supplier
U.S.A. Salmonella Testing Market Estimated Sales by Major Supplier
U.S.A. Shigella Testing Market Estimated Sales by Major Supplier
U.S.A. West Nile Virus Nat Market Reagent Sales by Major Supplier

Related Reports